Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
milestones
Biotech
Hansoh, Chugai ink separate and lucrative licensing agreements
A pair of licensing deals has emerged from Hansoh Pharma and Rani Therapeutics that together represent billions of dollars in potential payouts.
Fraiser Kansteiner
Oct 17, 2025 11:04am
Boehringer digs in on ADCs with $991M AimedBio licensing accord
Oct 15, 2025 10:05am
Sarepta sells 9M Arrowhead shares for $174M cash
Aug 13, 2025 5:44pm
Arrowhead meets $100M milestone, awaits Sarepta payment
Jul 28, 2025 3:10pm
Novo taps Photys for multi-molecule cardiometabolic collab
Dec 18, 2024 7:30am
Biopharma won’t stop betting big on M&A earnouts as payouts slow
Oct 17, 2023 6:00am